Miguel Forte, MD, PhD ISCT President mC4Tx Belgium We are just two months away from our ISCT Scientific Annual Meeting in New Orleans, under the theme of “ Driving Global Innovation Towards Patient Access ” . It will be the highlight moment of the year for all of us who are focused...
Miguel Forte, MD, PhD ISCT President mC4Tx Belgium The year 2024 was another great year for patients with unmet medical needs as strong progress was made with cell and gene therapy products. We saw 10 new product approvals in between Europe, with EMA, and the US with the FDA....
Miguel Forte, MD, PhD ISCT President mC4Tx Belgium Cell and gene therapy has come a long way, particularly since 2017 when the fantastic clinical outcomes and patient value that had been reported over the previous 5 year promised a great commercial opportunity with regulatory...
Miguel Forte, MD, PhD ISCT President mC4Tx Belgium Forty years ago, Steve Jobs made a visionary speech about the use of computers. People would be using computers all day long! He added that “people would be going to ask themselves, several years down the road, “if this was not always...
Jacques Galipeau, MD FRCP(C) President, ISCT Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health Cell and Gene Therapies (CGTs), especially at the intersection of gene-modified...
From the President’s Desk: Cell and Gene Therapies and air travel Closer than you think Jacques Galipeau, MD FRCP(C) President, ISCT Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of...
Jacques Galipeau, MD FRCP(C) ISCT President Don and Marilyn Anderson, Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health In 1968, a toddler with Wiscott-Aldrich syndrome – a lethal genetic bone marrow...
From the President’s Desk: Regionalism Adds Depth to the ISCT I nternational Vision Jacques Galipeau, MD FRCP(C) Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health The former...
From the President's Desk: Inaugural Letter By: Jacques Galipeau, MD FRCP(C) Don and Marilyn Anderson Professor in Oncology Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health You know cell & gene therapy (CGT) is in the...
From the President's Desk April 2022 Integration, Evolution, and Serendipity by: Bruce Levine, PhD President, ISCT United States Dear Colleagues and Friends, Hello and farewell from Philadelphia’s Cellicon Valley. As I’ve gathered my thoughts for these...
4 Comments - no search term matches found in comments.